We screened 145 subjects in the pulmonary function laboratory on the same day as they underwent lung function testing, from April 2006 to July 2008. A questionnaire concerning medical and smoking history and respiratory symptoms was administered. The diagnosis of COPD was made according to European Respiratory Society recommendations [18Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests Eur Respir J 2005; 26: 948-68.].

The diagnosis of OSA was confirmed in obese patients by standard overnight polysomnography according to criteria of the American Academy of Sleep Medicine [19American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research Sleep 1999; 22: 667-89.]. The subjects were divided into those with mild-moderate OSA (apnea-hypopnea index, AHI = 5-30), and those with severe OSA (AHI ≥30) [20Ferretti A, Giampiccolo P, Redolfi S, et al. Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers Respir Res 2006; 7: 54-64.]. A BMI of ≥30 was classified as obese [21Obesity: preventing and managing the global epidemic; report of a WHO consultation on obesity Geneva, Switzerland: World Health Organization 1997.]. Subjects were excluded if they had otolaryngological defects, use of hypnotic medications, asthma, or any acute cardiorespiratory disease. COPD patients and control subjects were excluded if they had symptoms of sleep apnea, and thus did not undergo sleep studies. Control subjects were individuals free of cardiorespiratory illness. The study was approved by the Institutional Review Board of the University of Southern California Health Sciences Campus, and an informed consent was obtained from each patient (IRB Proposal # HS-05-00412). The findings of this study were, in part, previously reported in abstract form [22Baydur A, Vigen C, Chen Z, Wilkinson L, Milic-Emili J. Expiratory flow limitation (EFL) in obstructive sleep apnea (OSA) and other respiratory disorders: Comparison of three analyses using negative expiratory pressure (NEP) method Am J Respir Crit Care Med 2009; 179: A6067.].

Spirometry and lung volumes by body plethysmography were performed while seated with a Collins GS/PLUS or DSII/PLUS system (Warren Collins; Braintree, MA). The cut-off point of the post-bronchodilator ratio between forced expiratory volume in 1 second (FEV₁) and forced vital capacity (FVC) COPD was 0.7. Predicted values for FEV₁, FVC and FEV₁/FVC were from Schoenberg et al. [23Schoenberg JB, Beck GJ, Bouhuys A. Growth and decay of pulmonary function in healthy blacks and whites Respir Physiol 1978; 33: 367-93.], and for subdivisions of lung volume from Crapo et al. [24Crapo RO, Morris AH, Clayton PD, et al. Lung volumes in healthy nonsmoking adults Bull Eur Physiopathol Respir 1982; 18: 419-25.].

Expiratory flow limitation (EFL) was assessed with an experimental setup (Fig. 1) as described by Valta et al. (6): A flanged rubber mouthpiece was connected in series to a heated No. 3 pneumotachograph (Fleisch; Lausanne, Switzerland) and an electromagnetically operated valve. The latter allowed rapid switching of the subject to negative pressure generated by a vacuum cleaner (Microstat; Kent; Elkhart, IN), whose power was adjusted by a variac (Ohmite Variac; Skokie, IL). The occlusion valve (Foon XP-1; McGill University; Montreal, Quebec, Canada) consisted of a spring-operated piston that remained closed and could be opened by activating the magnet with a software-generated digital signal. Flow was measured with a heated pneumotachograph and differential pressure transducer (Validyne MP-45, ± 2.5 cm H₂O; Validyne; Northridge, CA). The pneumotachograph was linear over the experimental range of flow. Volume was obtained by integration of digitized flow. Pressure at the airway opening was measured through a side port on the mouthpiece using a differential pressure transducer (Validyne MP-45, ± 50 cm H₂O; Validyne). The pressure transducer was calibrated before and after each study with a water manometer. The flow and pressure signals, generated with Validyne CD-19 carrier demodulators (Validyne), were passed through a 32-Hz, low pass filter and sampled at 100 Hz with a DASO8 12-bit analog-to-digital converter (Measurement Computing Corporation; Middleboro, MA). The computer used was a 25-MHz personal computer with a 14-inch monitor. Software, written in Microsoft Quick Basic (Microsoft; Redmond, WA), provided for real-time collection and display of flow, volume and pressure data as well as operator control. The occlusion valve was driven by the computer and had an opening time of 57 ms. It was activated when the expiratory flow reached a threshold level of 20 mL/s. Artifacts on the flow record caused by common mode rejection ratio were negligible [25Farré R, Navajas D, Peslin R, et al. A correction procedure for the asymmetry of differential pressure transducers in respiratory impedance measurements IEEE Trans Biomed Eng 1989; 136: 1137-40.].

Fig. (1) Diagram of negative expiratory pressure (NEP) apparatus. Pao, airway pressure; V’, flow. See text for details.

Fig. (2) Diagram of computations of %EFL and %AUC. NEP, negative expiratory pressure; EFL, expiratory flow limitation; %AUC, percent area of control expiratory curve occupied by the NEP curve. See text for details.

Fig. (3) Tidal and NEP curves in a control subject in seated position. Note how the expiratory flow increases above control flow upon application of NEP.

Fig. (4) Example of a subject with severe chronic obstructive pulmonary disease in supine posture exhibiting sustained absence in change of flow.

Fig. (5) Example of a subject with obstructive sleep apnea exhibiting sustained decrease in flow (>30% Vt) below control in seated position. Note the “sawtooth” pattern in both the control and NEP breaths during inspiration and expiration.

Fig. (6) Another example of a patient with severe OSA in supine posture. In this case, the decrease in flow with NEP was less sustained, although still >30% Vt.

Fig. (7) Another example of a patient with severe OSA in supine posture. In this case, application of NEP resulted in both a transient (<30% Vt) decrease and transient increase in flow. Note that the patient exhibited a transient decrease in expiratory flow during the control tidal breath even without application of NEP (note the dip in the central portion of the control tidal expiration).

Fig. (8) Expiratory Flow Limitation (% EFL) Data for Patients with Obesity Alone, Obstructive Sleep Apnea (OSA, mild-moderate, severe), COPD, and Control Subjects. Each notched box represents the 25th-75th percentile; internal line indicates the median; whiskers indicate the 10th and 90th percentiles. Notches extend to +/-1.58 inter-quartile range/sqrt (sample size). Notches that do not overlap suggest strong evidence of different medians. The general linear model used to model the ranks of the test variable as a function of the sitting and supine groups, adjusted for age and sex, showed significant differences amongst cohorts in the sitting posture, P=0.05, and amongst cohorts in the supine posture, P=0.005. ** Wilcoxon signed rank test (non-parametric paired-sample t-test) for comparisons between sitting and supine positions in each cohort.

Fig. (9) %AUC/%EFL for patients with obesity alone, obstructive sleep apnea (OSA, mild-moderate, severe), COPD, and control subjects. Each notched box represents the 25th-75th percentile; internal line indicates the median; whiskers indicate the 10th and 90th percentiles. Notches extend to +/-1.58 inter-quartile range/sqrt(sample size). Notches that do not overlap suggest strong evidence of different medians. The general linear model used to model the ranks of the test variable as a function of the sitting and supine groups, adjusted for age and sex, showed that the mild-moderate OSA patients exhibited the highest value of all cohorts in seated posture (significantly different from the seated COPD cohort only, P=0.04). There was no significant difference between sitting or supine position in any cohort [Wilcoxon signed rank test (non-parametric paired-sample t-test) for comparisons between sitting and supine positions in each cohort].

Subjects sat in a comfortable chair at least 1 or 2 hours after eating or drinking coffee. They breathed room air through the equipment assembly with a nose clip on. Each subject underwent a 3 min trial run in order to become accustomed to the procedure. Data acquisition began after regular breathing was achieved. NEP was applied throughout expiration for a series of 10 to 15 single breaths. As suggested by Ferretti et al. [20Ferretti A, Giampiccolo P, Redolfi S, et al. Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers Respir Res 2006; 7: 54-64.], to increase discrimination between cohorts, we used NEPs less than commonly reported (-2 to -3 cm H₂O instead of -5 to -10 cm H₂O) [7Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders Chest 2004; 125: 98-105.-9Liistro G, Veriter C, Dury M, et al. Expiratory flow-limitation in awake sleep-disordered breathing subjects Eur Respir J 1999; 14: 185-90., 12Verin E, Tardif C, Portier F, et al. Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea Thorax 2002; 57: 423-8.-14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13.]. Each test breath was followed by a 20- to 30-s period of regular breathing. These serial maneuvers were repeated with the subject lying on a comfortable gurney with head resting on a low pillow. Subjects were monitored for leaks at the mouthpiece. A closed system ensured that after the NEP tests the end-expiratory volume returned to the pre-NEP level, an important criterion for NEP breath analysis. Inspection of the breaths for this requirement ensured that 10 breaths from each set of breaths were acceptable for analysis. Coefficients of variation for intraindividual tidal volume (Vt), inspiratory time (Ti), and expiratory time (Te) were 5%-12% in both postures, as reported for normals and COPD [26Sorli J, Grassino A, Lorange G, et al. Control of breathing in patients with chronic obstructive lung disease Clin Sci Mol Med 1978; 54: 295-304.-28de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly Eur Respir J 2005; 26: 594-601.].

The expiratory flow-volume loops generated during application of NEP were compared by superimposition on those obtained during the immediately preceding breath (Fig. 2). After application of NEP, expiratory flow either increased above control flow throughout expiration, reflecting absence of EFL (Fig. 3), did not change from control, consistent with intrathoracic airway obstruction (Fig. 4), or decreased transiently (<30% control Vt span) (Fig. 7) or in a sustained manner (≥30% Vt span, two examples, Figs. 5, 6) throughout expiration reflecting, respectively, transient or sustained upper airway collapse [7Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders Chest 2004; 125: 98-105.-9Liistro G, Veriter C, Dury M, et al. Expiratory flow-limitation in awake sleep-disordered breathing subjects Eur Respir J 1999; 14: 185-90., 12Verin E, Tardif C, Portier F, et al. Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea Thorax 2002; 57: 423-8.-14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13.]. The term EFL used here encompasses all the types of flow limitation described, and is broader than the original definition of tidal EFL (i.e., absence of change in expiratory flow) as defined by Koulouris et al. [5Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing Am J Respir Crit Care Med 1994; 149: 352-57.].

EFL was computed by the following methods (Fig. 2):

1. EFL was expressed as percentage of the expired tidal volume over which the NEP-induced flow did not exceed spontaneous flow (%EFL) [5Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing Am J Respir Crit Care Med 1994; 149: 352-57., 6Valta P, Corbeil C, Lavoie A, et al. Detection of expiratory flow limitation during mechanical ventilation Am J Respir Crit Care Med 1994; 154: 1726-34.] for each subject in both postures as the median of 10 acceptable NEP breaths.
2. The degree to which the expiratory curve during NEP decreased below the preceding control expiratory curve was expressed as the percentage of the area under the control curve (%AUC), based on a modification of Tamisier et al. [14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13.]. This value was expressed as the median of the same10 acceptable NEP breaths in each posture.
3. To further enhance discrimination between COPD and OSA, we computed the ratio %AUC/%EFL because changes in %EFL and %AUC were not always of the same magnitude or direction. Thus, an increase %AUC/%EFL would indicate a greater degree of upper airway FL than intrathoracic EFL, while a decrease with preservation of %EFL would be more consistent with intrathoracic EFL. This new index was expressed as an arbitrary unit, as the median of the same 10 acceptable NEP breaths in each posture.

Because the data exhibited skewed distributions for many of the lung function variables, nonparametric statistical procedures were used [29Dixon WJ, Massey FJ Jr. Introduction to statistical analysis. 4th. New York: McGraw-Hill 1983; pp. 385-414.]. Intragroup medians and ranges were used where there were outlier values. These values were depicted as notched bar and whisker plots in order to highlight more clearly the significance in differences between cohorts. The notches surrounding the medians provide a measure of the rough significance of differences between the values. Specifically, if the notches about two medians do not overlap in this display, the medians are significantly different at about a 95% confidence level [30McGill R, Tukey JW, Larsen WA. Variations of box plots Am Stat 1978; 32: 12-6.]. For each of the variables investigated, the Kruskal-Wallis test (a non-parametric version of analysis of variance) was employed to assess differences in central tendency between subjects with non-OSA obesity, mild-moderate and severe obstructive sleep apnea, COPD, and control subjects. In order to perform similar analyses adjusting for age and gender, general linear models were used to model the ranks of test variables as a function of age, gender and cohort. The Wilcoxon signed rank test (a nonparametric analog of the paired-sample t-test) was used to test for differences between variables obtained in the seated and supine postures. The P-values for multiple comparisons amongst cohorts for each body position were adjusted by the Tukey-Kramer method.

Of 145 patients screened, excluded from analysis were 5 patients with asthma (according to ATS/ERS criteria), and one with congestive heart failure. The remaining 139 subjects consisted of 50 patients with documented OSA [26 mild-moderate (AHI 5-30), 24 severe (AHI >30)], 28 with non-OSA obesity, 42 with COPD, and 19 non-smoking healthy subjects (Table 1). The non-obese, mild-moderate OSA and severe OSA patients were well-matched in age, but the COPD patients were older, while the control subjects were younger. The BMIs of the non-OSA obese, the mild-moderate and severe OSA cohorts were, respectively, 62%, 63% and 87% greater than in the control subjects. FEV₁ in the non-OSA obese, OSA (mild-moderate), OSA (severe), and COPD subjects was 10%, 15%, 27% and 54% less, respectively, than in the controls (all statistically significant). The AHI in the severe OSA patients was, respectively, 47 and 3.8 times greater than in the obese and mild-moderate OSA groups.

Table 1.

Anthropometric and Physiologic Data for Patients with Non-Obesity, Obstructive Sleep Apnea (OSA, Mild-Moderate, Severe), COPD and Control Subjects

Fig. (8) shows that median %EFL in the severe OSA and COPD groups was, respectively, 2.6 and 3.5 times larger than the controls in supine position (severe OSA vs control: P=0.001; COPD vs control: P=0.001), and 2.9 and 4.4 times larger, respectively, than in the controls in the seated position (severe OSA vs control: P=0.01; COPD vs control: P=0.007), adjusted for age and gender.

There were no significant differences in %AUC amongst cohorts (not shown). Fig. (9) shows that the mild-moderate OSA patients tended to exhibit the highest value of %AUC/%EFL of all cohorts in seated posture, but this value was significantly different from only that of the COPD cohort (2.2 times higher than the COPD group, P=0.04). Otherwise, %AUC/%EFL did not differ significantly amongst cohorts because of spread in individual values.

Most subjects exhibited a transient decrease in flow in occasional NEP curves, mainly while in the supine posture. A sustained absence of change in flow in NEP breaths was primarily observed in COPD patients, consistent with intrathoracic flow limitation. Twelve of 17 seated and 22 of 25 supine COPD patients (mean FEV₁ 54% predicted) exhibiting sustained decreases in flow below control in occasional NEP breaths had BMIs ≥30. Their median %EFL, %AUC and %AUC/%EFL, however, did not differ significantly from the main COPD cohort. Two control subjects, aged 65 and 61 years, exhibited sustained absence of change in flow in occasional NEP breaths in both postures. Two other control subjects with transient decrease in flow during occasional NEP breaths in supine posture had BMIs just below the threshold for obesity (29.58 and 29.9).

We confirmed the usefulness of the NEP technique to assess upper airway collapsibility as shown previously [7Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders Chest 2004; 125: 98-105.-9Liistro G, Veriter C, Dury M, et al. Expiratory flow-limitation in awake sleep-disordered breathing subjects Eur Respir J 1999; 14: 185-90., 12Verin E, Tardif C, Portier F, et al. Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea Thorax 2002; 57: 423-8.-14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13., 28de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly Eur Respir J 2005; 26: 594-601., 31Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory flow limitation and orthopnea in massively obese subjects Chest 2001; 119: 1401-8.-34Baydur A, Milic-Emili J. Expiratory flow limitation during spontaneous breathing Chest 1997; 112: 1017-23.]. Moreover, our findings of higher %EFL in COPD compared to controls confirm findings of previous studies [5Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing Am J Respir Crit Care Med 1994; 149: 352-57., 7Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders Chest 2004; 125: 98-105., 28de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly Eur Respir J 2005; 26: 594-601., 29Dixon WJ, Massey FJ Jr. Introduction to statistical analysis. 4th. New York: McGraw-Hill 1983; pp. 385-414.]. Our finding of variability in measurements using the NEP technique was also reported by Walker et al. [35Walker R, Paratz J, Holland AE. Reproducibility of the negative expiratory pressure technique in COPD Chest 2007; 132: 471-6.] and Hadcroft and Calverley [36Hadcroft J, Calverley PMA. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Thorax 2001; 56: 713-20.] and is likely due to a number of factors, discussed below.

Percent AUC tended to be greater in seated OSA patients indicating that mechanisms maintaining upper airway patency while supine were operational. By contrast, %AUC was greatest in supine COPD patients, almost double its seated median. Thus, mechanisms preserving patency in supine COPD patients may not be as effective as in obese or OSA individuals. Reductions in lung volume (as occur in supine posture) cause decreases in caudal traction on the upper airway and concomitant increases in upper airway collapsibility [37Thut DC, Schwartz AR, Roach D, Wise RA, Permutt S, Smith PL. Tracheal and neck position influence upper airway flow dynamics by altering airway length J Appl Physiol 1993; 75: 2084-90.-40Owens RL, Malhotra A, Eckert DJ, White DP, Jordan AS. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility J Appl Physiol 2010; 108: 445-51.]. Furthermore, supine positioning promotes laryngeal edema and upper airway narrowing [40Owens RL, Malhotra A, Eckert DJ, White DP, Jordan AS. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility J Appl Physiol 2010; 108: 445-51.-42Jafari B, Mohsenin V. Overnight rostral fluid shift in obstructive apnea Chest 2011; 140: 991-7.]. In COPD, mobilization of secretions when supine may have contributed to this finding. Yet, the finding of an overall increase in %EFL in supine position without concomitant increases in %AUC (or %AUC/%EFL) in most cohorts indicates a greater degree of intrathoracic tidal EFL [as defined by Koulouris et al. [5Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing Am J Respir Crit Care Med 1994; 149: 352-57.] than extrathoracic FL. This is likely related to decrease in lung volume in supine posture.

Some explanations for the inconsistent findings: During early expiration, there is post-inspiratory inspiratory activity (PIIA) which may counteract the effect of NEP. At the beginning of expiration, PIIA may oppose NEP [resistance posed by pliometric contraction (= lengthening) of the inspiratory muscles] [43Shee CD, Ploy-song-sang Y, Milic-Emili J. Decay of inspiratory muscle pressure during expiration in conscious humans J Appl Physiol 1985; 58: 1859-65.]. This implies that NEP should not be applied too early in expiration (when PIIA is high). In our subjects, NEP was applied immediately after the onset of expiratory flow so that PIIA is likely to have influenced heterogeneity of EFL within cohorts.

Our method for computing %AUC is similar to that of Tamisier et al. [14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13.] who devised a quantitative index corresponding to the ratio of the area under the expiratory flow-volume curves between NEP and control tidal volume. They did not, however, study subjects with mild OSA (BMI 5-15), and the age of their controls was somewhat younger (mean 34 years). They also applied NEP near end-expiratory volume which stimulates activation of the genioglossus [3Suratt PM, White DP. Evaluations of the upper airway in patients with obstructive apnea Sleep 1991; 14: 361-71., 44Tantucci C, Mehiri S, Duguet A, et al. Application of negative expiratory pressure during expiration and activity of genioglossus in humans J Appl Physiol 1998; 84: 1076-82.]. This can alter the area under the terminal portion of the NEP curve, affecting the quantitative index used to assess the upper airway collapsibility. Our results suggest that obese and OSA patients are more likely to experience upper airway narrowing while seated than COPD patients, indicating reduced PIIA and genioglossus activity in that posture. The severe OSA patient shown in Fig. (5) exhibited abolition of “sawtoothing” and modest decreases in %EFL and %AUC while supine, consistent with increased PIIA and genioglossus activity. Two control subjects exhibited EFL (with absence of change in tidal flow in some NEP breaths) in both postures; both were in their 60s and did not experience dyspnea. Expiratory flow limitation is known to occur in some older patients, even in the presence of normal FEV₁/FVC and absence of dyspnea [28de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly Eur Respir J 2005; 26: 594-601.].

These considerations raise a potential limitation in our methods. Our study and those of others [7Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders Chest 2004; 125: 98-105.-9Liistro G, Veriter C, Dury M, et al. Expiratory flow-limitation in awake sleep-disordered breathing subjects Eur Respir J 1999; 14: 185-90., 12Verin E, Tardif C, Portier F, et al. Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea Thorax 2002; 57: 423-8.-14Tamisier R, Wuyam B, Nicolle I, et al. Awake flow limitation with negative expiratory pressure in sleep disordered breathing Sleep Med 2005; 6: 205-13., 28de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly Eur Respir J 2005; 26: 594-601., 31Ferretti A, Giampiccolo P, Cavalli A, Milic-Emili J, Tantucci C. Expiratory flow limitation and orthopnea in massively obese subjects Chest 2001; 119: 1401-8.-33Rouatbi S, Tabka Z, Dogui M, Abdelghani A, Guénard H. Negative expiratory pressure (NEP) parameters can predict obstructive sleep apnea syndrome in snoring patients Lung 2009; 187: 23-8.] are based on the assumption that upper airway collapsibility can be identified only when expiratory flow during NEP decreases below the control curve. However, pharyngeal collapse can also occur with a smaller increase in expiratory flow during NEP [20Ferretti A, Giampiccolo P, Redolfi S, et al. Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers Respir Res 2006; 7: 54-64.]. Thus, detecting upper airway collapsibility only by computing the span of the preceding control tidal volume over which the NEP curve drops below the control breath can be misleading. It is possible that some patients with upper airway collapsibility may not have been identified if they exhibited only a reduction in the increase of expiratory flow during NEP. However, since we were primarily interested in discriminating patients with COPD from those with obesity and OSA, the same methods for quantifying EFL were used in all cohorts.

Another limitation in our study was that sleep studies were not obtained in our COPD patients and controls. Sleep-related disordered breathing (SDB) and nocturnal desaturations have been reported in COPD patients, giving rise to an “overlap syndrome” although not all SDB could be classified as frank sleep apnea [45Caterall JR, Douglas NJ, Calverley PM, et al. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome Am Rev Respir Dis 1983; 126: 206-10., 46Aoki T, Ebihara A, Salamaki F, et al. Sleep disordered breathing in patients with chronic obstructive disease COPD 2005; 2: 243-52.]. We were careful, however, in excluding subjects with symptoms of sleep apnea in both cohorts. None of the obese COPD patients gave a history of snoring or symptoms of sleep apnea.

In conclusion, the %EFL and %AUC methods are useful in determining the magnitude of intrathoracic or extrathoracic FL in patients with COPD and OSA, but fail to distinguish cohorts on the basis of EFL quantification using the area under the curve method because of interindividual variabilities. Pattern recognition of NEP tracings remains the best way to distinguish intrathoracic from extrathoracic EFL.